Kinase inhibitions in pyrido[4,3-h] and [3,4-g]quinazolines: Synthesis, SAR and molecular modeling studies

被引:10
作者
Zeinyeh, Wael [1 ]
Esvan, Yannick J. [1 ]
Josselin, Beatrice [2 ]
Baratte, Blandine [2 ]
Bach, Stephane [2 ]
Nauton, Lionel [1 ]
Thery, Vincent [1 ]
Ruchaud, Sandrine [2 ]
Anizon, Fabrice [1 ]
Giraud, Francis [1 ]
Moreau, Pascale [1 ]
机构
[1] Univ Clermont Auvergne, CNRS, SIGMA Clermont, ICCF, F-63000 Clermont Ferrand, France
[2] Sorbonne Univ, Plateforme Criblage KISSf Kinase Inhibitor Specia, Prot Phosphorylat & Human Dis Unit, CNRS,Stn Biol, Pl Georges Teissier, F-29688 Roscoff, France
关键词
Pyrido[3,4-g]quinazolines; Pyrido[4,3-h]quinazoline; Protein kinase inhibition; CLK1; CLK1; DERIVATIVES; DYRK1A;
D O I
10.1016/j.bmc.2019.04.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
New pyrido[3,4-g]quinazoline derivatives were prepared and evaluated for their inhibitory potency toward 5 protein kinases (CLK1, DYRK1A, GSK3, CDK5, CK1). A related pyrido[4,3-h]quinazoline scaffold with an angular structure was also synthesized and its potency against the same protein kinase panel was compared to the analogous pyrido[3,4-g] quinazoline. Best results were obtained for 10-nitropyrido[3,4-g]quinazoline 4 toward CLK1 with nanomolar activities.
引用
收藏
页码:2083 / 2089
页数:7
相关论文
共 20 条
[1]   DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications [J].
Abbassi, Ramzi ;
Johns, Terrance G. ;
Kassiou, Michael ;
Munoz, Lenka .
PHARMACOLOGY & THERAPEUTICS, 2015, 151 :87-98
[2]   Roscovitine targets, protein kinases and pyridoxal kinase [J].
Bach, S ;
Knockaert, M ;
Reinhardt, J ;
Lozach, O ;
Schmitt, S ;
Baratte, B ;
Koken, M ;
Coburn, SP ;
Tang, L ;
Jiang, T ;
Liang, DC ;
Galons, H ;
Dierick, JF ;
Pinna, LA ;
Meggio, F ;
Totzke, F ;
Schächtele, C ;
Lerman, AS ;
Carnero, A ;
Wan, YQ ;
Gray, N ;
Meijer, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (35) :31208-31219
[3]   CHEMISTRY OF INDOLO[1,2-C]QUINAZOLINE - AN APPROACH TO THE MARINE ALKALOID HINCKDENTINE-A [J].
BILLIMORIA, AD ;
CAVA, MP .
JOURNAL OF ORGANIC CHEMISTRY, 1994, 59 (22) :6777-6782
[4]   Meriolins (3-(pyrimidin-4-yl)-7-azaindoles): Synthesis, kinase inhibitory activity, cellular effects, and structure of a CDK2/cyclin A/meriolin complex [J].
Echalier, Aude ;
Bettayeb, Karima ;
Ferandin, Yoan ;
Lozach, Olivier ;
Clement, Monique ;
Valette, Annie ;
Liger, Franrcois ;
Marquet, Bernard ;
Morris, Jonathan C. ;
Endicott, Jane A. ;
Joseph, Benoit ;
Meijer, Laurent .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (04) :737-751
[5]   Development of Selective Clk1 and-4 Inhibitors for Cellular Depletion of Cancer-Relevant Proteins [J].
ElHady, Ahmed K. ;
Abdel-Halim, Mohammad ;
Abadi, Ashraf H. ;
Engel, Matthias .
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (13) :5377-5391
[6]   Formamidines - Versatile Ligands for Zinc-Catalyzed Hydrosilylation and Iron-Catalyzed Epoxidation Reactions [J].
Enthaler, Stephan ;
Schroeder, Kristin ;
Inoue, Shigeyoshi ;
Eckhardt, Bjoern ;
Junge, Kathrin ;
Beller, Matthias ;
Driess, Matthias .
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, 2010, 2010 (25) :4893-4901
[7]   Discovery of pyrido[3,4-g]quinazoline derivatives as CMGC family protein kinase inhibitors: Design, synthesis, inhibitory potency and X-ray co-crystal structure [J].
Esvan, Yannick J. ;
Zeinyeh, Wael ;
Boibessot, Thibaut ;
Nauton, Lionel ;
Thery, Vincent ;
Knapp, Stefan ;
Chaikuad, Apirat ;
Loaec, Nadege ;
Meijer, Laurent ;
Anizon, Fabrice ;
Giraud, Francis ;
Moreau, Pascale .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 118 :170-177
[8]  
Frisch M.J., 2016, GAUSSIAN 16
[9]   Human CDC2-Like Kinase 1 (CLK1): A Novel Target for Alzheimer's Disease [J].
Jain, Princi ;
Karthikeyan, Chandrabose ;
Hari Narayana Moorthy, N. S. ;
Waiker, Digambar Kumar ;
Jain, Arvind Kumar ;
Trivedi, Piyush .
CURRENT DRUG TARGETS, 2014, 15 (05) :539-550
[10]   Mild synthesis of N′-aryl-N,N-dimethylformamidinium chloride by Vilsmeier-Haack reagent [J].
Meng, Ge ;
Sha, Yao Wu ;
Zhang, Rui ;
Bai, Nan .
CHINESE CHEMICAL LETTERS, 2011, 22 (09) :1043-1046